Tauns

Basic Information

Stock Code
197A
Industry
Pharmaceuticals
Category Detail
Biotechnology & Pharmaceuticals
Prefecture
Shizuoka Prefecture
Establishment Year
April 2016
Listing Year
June 2024
Official Website
https://www.tauns.co.jp/
TSE Information
TSE Information
Yahoo! Finance
Yahoo! Finance
Other Companies
Tasuki HD, KG Information, Atect, Eiken Chemical, Kainos, Institute of Immunology, Mizuho Medy, Sysmex

Overview

Tauns is a pharmaceutical company established in 2016, holding the top domestic market share in antigen test kits for infectious diseases and is a leading company strong in antibody research.

Current Situation

Tauns listed on the Tokyo Stock Exchange in 2024, with surging sales of infectious disease-related products. Its flagship antigen test kits hold a top domestic market share, and development of simple tests for chronic diseases is progressing. The company focuses on technology development, leveraging proprietary antibody testing technology. Aiming for sustainable medical provision, it is also working to reduce environmental impact. For the fiscal year ending June 2025, it anticipates 4% profit growth, with product lineup expansion and market expansion as key strategies. Despite fierce market competition, it aims for stable growth backed by a solid technological foundation and customer trust. Plans include introducing emerging technologies and expanding diagnostic equipment.

Trivia

Interesting Facts

  • Grew into a leader in the test kit market in just a few years since founding.
  • Achieves high precision in test results through proprietary technology.
  • Implements infectious disease countermeasures support through collaboration with local governments.
  • Actively incorporates AI technology into product development.
  • Approximately 70% of R&D staff hold PhDs.
  • Receives high evaluations from many medical institutions.
  • Products have obtained multiple patents domestically and internationally.
  • Published numerous academic papers in antibody testing research.
  • Comprehensive employee health support programs.
  • Deploying online diagnostic linkage services.
  • Gained rapid attention in the industry during the COVID-19 pandemic.
  • Conducting joint research with major pharmaceutical companies.
  • Provides health-oriented meals in the company cafeteria.
  • Approximately 30% female employees, promoting diversity.
  • President is a young researcher background with strong technology focus.

Hidden Connections

  • Advancing technological collaboration with Nikkei competitor Mizuho Medy through capital and business alliance.
  • Regularly holds cross-industry exchange meetings with competitors like Institute of Immunology for information sharing.
  • Promoting joint research with local medical institutions in Shizuoka Prefecture as part of regional medical support.
  • Reports indicate cooperative relationship with Tasuki HD in distribution.
  • Ongoing industry-academia collaboration projects with multiple universities.
  • Many key executives from major pharmaceutical companies, strong in technology and management.
  • Collaborating with IT companies like Face Network to test remote diagnostics.
  • Deploying products for developing countries through cooperation with international health organizations.

Future Outlook

Growth Drivers

  • Increasing and diversifying demand for infectious disease testing
  • Expansion into chronic disease testing field
  • Continuous evolution of high-precision testing technology
  • Rising public health awareness
  • Accelerated entry into emerging overseas markets
  • Popularization of multiplex test products
  • Expansion of IT-utilizing testing solutions
  • Growing demand for sustainable healthcare
  • Expansion of healthcare linkage services
  • New technology launches through strengthened R&D
  • Government strengthening of infectious disease countermeasures policies
  • Deepening partnerships with medical institutions

Strategic Goals

  • Achieve 70% domestic market share in infectious disease testing
  • Establish position in chronic disease simple testing market
  • Realize overseas sales ratio of over 40%
  • 90% eco-friendly product ratio
  • Build next-generation testing system utilizing AI technology
  • Complete sustainable production and logistics system
  • Deploy multifaceted healthcare services
  • Strengthen collaboration with international health organizations
  • Improve employee diversity and work-life balance
  • Acquire 10 or more new patents annually

Business Segments

Testing Solutions for Medical Institutions

Overview
Provides test products and services tailored to diagnostic needs of medical institutions.
Competitiveness
High-precision testing technology and rapid delivery system
Customers
  • Hospitals
  • Clinics
  • Medical testing centers
  • Clinics
Products
  • Infectious disease antigen test kits
  • Multiplex test kits
  • Testing consumables
  • Research reagents

Reagent and Equipment Sales for Research Institutions

Overview
Provides high-quality reagents and equipment for research and development.
Competitiveness
Specialized technical support system
Customers
  • University labs
  • Corporate research institutes
  • Biotechnology companies
Products
  • Antibody reagents
  • Genetic testing reagents
  • Research measurement equipment

Contract Analysis Services for Pharmaceutical Companies

Overview
Deploys contract analysis services supporting pharmaceutical development.
Competitiveness
High technical expertise and confidentiality compliance
Customers
  • Pharmaceutical manufacturers
  • Biopharmaceutical developers
Products
  • Antibody analysis services
  • Clinical trial support
  • Quality control testing

Testing and Support Services for Public Institutions

Overview
Supports public health management and epidemiological surveys for public institutions.
Competitiveness
Proven track record and reliability with public institutions
Customers
  • Ministry of Health, Labour and Welfare
  • Local governments
  • Health centers
Products
  • Infectious disease test kit supply
  • Technical training support
  • Epidemiological survey support

Training Materials and Support for Educational Institutions

Overview
Provides specialized teaching materials and support services for medical education.
Competitiveness
Provision of latest industry technologies in education
Customers
  • Medical universities
  • Vocational schools
  • Training centers
Products
  • Educational test kits
  • Technical training programs

Overseas Market Development and Support

Overview
Deploys product supply and technical support tailored to overseas needs.
Competitiveness
Extensive experience in local regulatory compliance
Customers
  • Overseas medical institutions
  • Global partners
Products
  • Export test kits
  • Technology transfer support

Industrial Health Check Services

Overview
Provides health management support products for industry.
Competitiveness
Custom-made solutions for corporations
Customers
  • Major corporations
  • Occupational safety and health organizations
Products
  • Workplace simple test kits
  • Health management support

Support for Logistics and Sales Partners

Overview
Provides support services to streamline distribution.
Competitiveness
Efficient supply system development
Customers
  • Medical wholesalers
  • Distributors
Products
  • Logistics management systems
  • Product training programs

Product Development for Environmental Testing

Overview
Develops test equipment and reagents for environmental conservation.
Competitiveness
High-sensitivity and rapid detection technology
Customers
  • Environmental analysis institutions
  • Local government environmental departments
Products
  • Environmental monitoring test kits
  • Contaminant measurement reagents

Testing Products for Animal Healthcare

Overview
Provides test products for the animal healthcare market.
Competitiveness
Compatibility with diverse animal species
Customers
  • Animal hospitals
  • Veterinary research institutes
Products
  • Animal antigen test kits
  • Veterinary reagents

Information System Development and Provision

Overview
Provides IT solutions supporting efficiency in testing operations.
Competitiveness
Design tailored to medical sites
Customers
  • Medical institutions
  • Testing facilities
Products
  • Test data management systems
  • Automated analysis software

Consulting and Technical Support

Overview
Services for technological improvement and operational support for testing institutions.
Competitiveness
Extensive track record in the medical field
Customers
  • Medical corporations
  • Testing institutions
Products
  • Operational optimization support
  • Technical training services

Competitive Advantage

Strengths

  • Domestic top-class antigen testing technology
  • Proprietary antibody R&D capabilities
  • Rapid product development cycle
  • Strong customer base and trust
  • Diverse test product lineup
  • Advanced quality control system
  • Proven collaboration with public institutions
  • Flexible customization response
  • Active adoption of latest technologies
  • Stable logistics and supply network
  • High R&D investment ratio
  • Comprehensive technical support
  • Diverse sales channels
  • Rapid response to market changes
  • High regulatory compliance

Competitive Advantages

  • High market share and brand recognition in domestic infectious disease testing
  • Superior performance with innovative antigen and antibody testing technology
  • First-mover advantage through rapid product development
  • Broad coverage of customer needs with diverse product composition
  • Strong partnerships with public and medical institutions
  • Reliability ensured by advanced quality control
  • Flexible and rapid customer support system
  • Rapid product launches for emerging infectious diseases
  • Technological superiority through latest biotechnology utilization
  • Superior compliance system for domestic and international regulations
  • Environmentally considerate product design and manufacturing processes
  • Strengthened online and offline sales channels
  • Product customization capabilities for diverse customer segments
  • Faster market response than competitors
  • Robust intellectual property from research achievements

Threats

  • Rise of domestic and international competitors
  • Uncertain outbreaks of novel infectious diseases
  • Development delays due to stricter regulations and certifications
  • Cost increases from raw material price fluctuations
  • Obsolescence of existing products due to technological evolution
  • Impact of exchange rate fluctuations on international business
  • Growth slowdown from domestic market maturity
  • Cybersecurity risks
  • Intellectual property infringement risks
  • Legal litigation risks
  • Supply chain disruption risks
  • Demand fluctuations from changes in infectious disease prevention policies

Innovations

2024: Chronic Disease Simple Test Kit Development

Overview
Developed at-home simple test kits for diabetes and dyslipidemia.
Impact
Contributes to new market creation and sales expansion

2024: Multiplex Infectious Disease Test Kit Introduction

Overview
Launched kits enabling simultaneous testing for multiple infectious diseases.
Impact
Significantly improves testing efficiency

2023: Mobile Testing Device Development

Overview
Realized on-site rapid testing with portable testing equipment.
Impact
Greatly transforms testing environments and contributes to market expansion

2022: Antibody Analysis Contract Service Launch

Overview
Launched high-precision antibody analysis services for pharmaceutical companies.
Impact
Successfully created new revenue sources and expanded customer base

2021: High-Sensitivity Antigen Testing Technology Patent Acquisition

Overview
Acquired patent for sensitivity-enhancing technology to strengthen differentiation.
Impact
Contributes to maintaining and expanding competitive edge

2020: At-Home Testing Service Launch

Overview
Introduced at-home testing services in response to novel coronavirus.
Impact
Contributes to improved customer convenience and new customer acquisition

Sustainability

  • Development of low-environmental-impact reagent packaging
  • Promotion of medical waste reduction projects
  • Introduction of energy-saving production equipment
  • Strengthening of regional medical support volunteering
  • Promotion of sustainable raw material procurement
  • Thorough employee health and safety management
  • Environmental management across entire product lifecycle
  • Setting and achievement of CO2 emission reduction targets
  • Active utilization of green IT
  • Promotion of diversity and inclusion